Results 191 to 200 of about 28,144 (206)

Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation

Thrombosis Research, 2015
Mika Skeppholm, Fadiea Al-Aieshy
exaly  

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

British Journal of Clinical Pharmacology, 2013
Wonkyung Byon
exaly  

Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial

Journal of the American College of Cardiology, 2020
Philippe Gabriel Steg, Christina Christersson, Michel Zeitouni   +2 more
exaly  

APIXABAN FORMULATIONS

2011
PATEL JATIN, FROST CHARLES, JIA JINGPIN, VEMA-VARAPU CHANDRA   +3 more
openaire   +13 more sources

Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis

International Journal of Cardiology, 2013
Anne Godier, Anne-Céline Martin, Bernard le Bonniec   +2 more
exaly  

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factorXa inhibitor

British Journal of Clinical Pharmacology, 2015
Frank Lacreta
exaly  

Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

Journal of Stroke and Cerebrovascular Diseases, 2012
Martin O'Donnell, Raffaele de Caterina, John Eikelboom   +2 more
exaly  

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

Research and Practice in Thrombosis and Haemostasis, 2018
Hillary Maitland, Tri Le, Surabhi Palkimas   +2 more
exaly  

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factorXa inhibitor, in healthy subjects

British Journal of Clinical Pharmacology, 2013
Frank Lacreta
exaly  

Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict

Expert Opinion on Investigational Drugs, 2008
Jack Ansell
exaly